Naproxen Sodium
NDC 50844-604, Naproxen Sodium, tablet, film coated, from L.N.K. International, Inc..
- Product NDC
- 50844-604
- Status
- Listed
- Labeler
- L.N.K. International, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA204872
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50844-604 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50844-604-06 | 50844060406 | 200 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-604-06) |
| 50844-604-09 | 50844060409 | 4 BLISTER PACK in 1 CARTON (50844-604-09) / 5 TABLET, FILM COATED in 1 BLISTER PACK |
| 50844-604-14 | 50844060414 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-604-14) |
| 50844-604-15 | 50844060415 | 1 BOTTLE, PLASTIC in 1 CARTON (50844-604-15) / 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| 50844-604-16 | 50844060416 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-604-16) |
| 50844-604-19 | 50844060419 | 1 BOTTLE, PLASTIC in 1 CARTON (50844-604-19) / 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| 50844-604-56 | 50844060456 | 25 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-604-56) |
| 50844-604-98 | 50844060498 | 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-604-98) |
| 50844-604-99 | 50844060499 | 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-604-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50844-604 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50844-604 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50844-604. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.